Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Exicure Inc (XCUR)

Exicure Inc (XCUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Exicure Inc 2430 N. Halsted St. Chicago IL 60614 USA

www.exicuretx.com Employees: 6 P: 847-673-1700 F: 847-556-6411

Description:

Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States.

Key Statistics

Overview:

Market Capitalization, $K 42,082
Enterprise Value, $K 41,262
Shares Outstanding, K 2,606
Annual Sales, $ 0 K
Annual Net Income, $ -16,910 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -600 K
EBIT, $ -6,900 K
EBITDA, $ -5,520 K
60-Month Beta 3.59
% of Insider Shareholders 8.40%
% of Institutional Shareholders 42.82%
Float, K 2,387
% Float 91.60%
Short Volume Ratio 0.41

Growth:

1-Year Return 371.14%
3-Year Return -46.03%
5-Year Return -96.06%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.57 on 11/14/24
Next Earnings Date 08/09/24
Earnings Per Share ttm -4.55
EPS Growth vs. Prev Qtr -62.86%
EPS Growth vs. Prev Year 81.31%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 08/28/24

XCUR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -190.90%
Return-on-Assets % -36.75%
Profit Margin % 0.00%
Debt/Equity 0.62
Price/Sales 58.93
Price/Cash Flow N/A
Price/Book 19.69
Book Value/Share 0.93
Interest Coverage -0.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar